References
- Huguley C M, Jr. Agranulocytosis induced by dipyrone, a hazardous antipyretic and analgesic. JAMA 1964; 189: 938–941, [PUBMED], [INFOTRIEVE]
- Okonek S. Intoxication with pyrazolones. Br J Clin Pharmacol 1980; 10(Suppl 2)385S–390S, [PUBMED], [INFOTRIEVE]
- Haas H. History of antipyretic analgesic therapy. Am J Med 1983; 75: 1–3, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dipyrone. Martindale—The Complete Drug Reference, Healthcare Series, Thompson–Micromedex, Greenwood Village, CO 2003; Vol. 116
- Dipyrone. The Merck Index13th ed, M S O'Neill. Merck & Co., Inc., Whitehouse Station, NJ 2001; 589–590
- Dipyrone. Drugdex, Healthcare Series, Thompson–Micromedex, Greenwood Village, CO 2003; Vol. 116
- Frolich J C, Rupp W A, Zapf R M, Badian M J. The effects of metamizol on prostaglandin synthesis in man. Agents Actions Suppl 1986; 19: 155–166, [PUBMED], [INFOTRIEVE]
- Abbate R, Gori A M, Pinto S, Attanasio M, Paniccia R, Coppo M, Castellani S, Giusti B, Boddi M, Neri Serneri G G. Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone. Prostaglandins, Leukot Essent Fat Acids 1990; 41: 89–93, [CROSSREF]
- The International agranulocytosis and aplastic amemia study. Risks of agranulocytosis and aplastic amemia. JAMA 1986; 256: 1749–1757, [CROSSREF]
- Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 2002; 58: 265–274, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vlahov V, Bacracheva N. Agranulocytosis and dipyrone. Lancet 1989; 2: 1215, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bonkowsky J L, Frazer J K, Buchi K F, Byington C L. Metamizole use by Latino immigrants: a common and potentially harmful home remedy. Pediatrics 2002; 109: e98, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Taylor L, Abarca S, Henry B, Friedman L. Use of neo‐melubrina, a banned antipyretic drug, in San Diego, California: a survey of patients and providers. West J Med 2001; 175: 159–163, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Persson H E, Sjoberg G K, Haines J A, Pronczuk de Garbino J. Poisoning severity score. Grading of acute poisoning. J Toxicol, Clin Toxicol 1998; 36: 205–213, [CSA]
- Litovitz T L, Smilkstein M, Felberg L, Klein‐Schwartz W, Berlin R, Morgan J L. 1996 Annual report of the American association of poison control centers toxic exposure surveillance system. Am J Emerg Med 1997; 15: 447–500, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vlahov V, Badian M, Verho M, Bacracheva N. Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium. Eur J Clin Pharmacol 1990; 38: 61–65, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Flusser D, Zylber‐Katz E, Granit L, Levy M. Influence of food on the pharmacokinetics of dipyrone. Eur J Clin Pharmacol 1988; 34: 105–107, [PUBMED], [INFOTRIEVE]
- Levy M, Zylber‐Katz E, Rosenkranz B. Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinet 1995; 28: 216–234, [PUBMED], [INFOTRIEVE], [CSA]
- Asmardi G, Jamali F. Pharmacokinetics of dipyrone in man; role of the administration route. Eur J Drug Metab Pharmacokinet 1985; 10: 121–125, [PUBMED], [INFOTRIEVE]
- Levy M, Flusser D, Zylber‐Katz E, Granit L. Plasma kinetics of dipyrone metabolites in rapid and slow acetylators. Eur J Clin Pharmacol 1984; 27: 453–458, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zylber‐Katz E, Granit L, Stessman J, Levy M. Effect of age on the pharmacokinetics of dipyrone. Eur J Clin Pharmacol 1989; 36: 513–516, [CROSSREF]
- Okonek S, Reinecke H J. Acute toxicity of pyrazolones. Am J Med 1983; 75: 94–98, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wolhoff H, Altrogge G, Pola W, Sistovaris N. Metamizol—acute overdose with suicidal intent. Dtsch Med Wochenschr 1983; 108: 1761–1764, [German][PUBMED], [INFOTRIEVE]